European
AIDS Treatment
Group

EATG endorses this letter by the EU4Health Civil Society Alliance urging the EU Commission to ensure immediate adoption of the 2025 EU4Health Work Plan, and approve full-year funding for civil society under existing Framework Partnership Agreements.

A European Community Advisory Board (ECAB) meeting between members from EATG and Gilead Sciences (April 10, 2025) and ViiV Healthcare (April 11, 2025) will be held in Warsaw to discuss topics of interest to the community, such as questions related to safety and implementation of new HIV treatments.

EATG’s SCOPE is organising a workshop to bring together community workers from across Europe and Central Asia to exchange on challenges and good, innovative practices in delivering person-centred HIV prevention services. This is an in-person workshop that will take place between 30 June to 2 July in Berlin, Germany. Apply to attend.

EATG is excited to announce the recruitment of six new members to form part of the Community Advisory Group (CAG) under the READI project. The CAG is expected to play a crucial role in advising on Task 6.1 which centres on developing and reinforcing the different connections and partnerships by mapping community stakeholder connectivity, needs, and expectations.

The Viromarkers project will be launched in Rome, Italy, on April 3 and 4.  More than fifty researchers, industrial and community partners will gather from several European countries to give start to this ambitious cross-sectoral, public-private research partnership.

By Amanita Calderón-Cifuentes We live within syndemics—because no disease exists in isolation. It is through the convergence of multiple structural and social factors—transphobia and cisnormativity, queerphobia and heteronormativity, sexism, whorephobia, narcophobia, racism, and xenophobia—that the health of entire populations is shaped and often compromised. This is where intersectionality becomes essential to understanding the prevalence of HIV among key populations. For even within our differences, we are interconnected. In each of us lives a story that bears the weight of systemic violence and hate—but also the resilience, the defiance, and the collective pride of a community rooted in love and solidarity.

By Daniela Rojas Castro Research, the kind all of us in this room do, is not just about numbers or papers. It is a lifeline. It’s how we develop better treatments, safer strategies, and more inclusive approaches. It’s how we learn what truly works — especially for the people most often left behind. And now that lifeline is being cut short. Defend science. Defend communities.

Inclusion of Women and Transgender People in Clinical Trials: Advancing Equity in Research is a thematic meeting, organised as part of the EATG Belong project. The symposium takes place in Barcelona on 5 April (13:40-14:40). This symposium is held in the framework of the 15th International Workshop on Women & HIV.  

EATG has released an updated resource on DoxyPEP (doxycycline post-exposure prophylaxis) to provide a community-informed document on a prevention strategy, the implementation of which varies widely around the world. This master document provides a concise overview of the latest science and practices around DoxyPEP and a list of resources, including guidelines and recommendations.

On March 5, 2025, Nataliia Gerasymchuk, EATG CORE Project Manager, took part in the policy event in the European Parliament “Health Equity for Marginalised Voices: EU’s Path Forward” organised by the Nobody Left Outside initiative and co-hosted by MEPs Vytenis Andriukaitis, Tilly Metz and Stine Bosse.

We wrote to GSK regarding their recently reported decision to suspend diversity work within the company. This goes completely against previously stated plans to improve global health and improve clinical research. GSK is a huge global pharmaceutical company that surely cannot react to the whims of any one country in this manner. We are appalled at this decision and call for it to be revoked immediately.

The Community Breakfast Club are one-hour Zooms that provide an informal and friendly setting for dialogue between researchers and community advocates on the hottest CROI2025 science being presented this year.

EATG women converse with a legendary HIV activist from Albania. Olimbi managed to fight through hardship and change the face of the HIV/AIDS response in her country. When access to HIV treatment and care for her and her children weren’t available, she took things into her hands. She stood stronger by love, not by choice.

This year, EATG’s annual General Assembly takes place virtually on 10-11 May. We are taking stock of achievements and challenges from the previous 12 months as well as we are voting and deciding on our next steps and representation in the EATG bodies.  

ReCAP is a series of interviews with the members of the RBDCOV Community Advisory Panel that will explore the world of community engagement in EU projects and the importance of including people living with immunocompromising conditions in clinical trials. Our guests for this interview are Mona Sundnes and Jenny Camaradou, members of the Community Advisory Panel for the RBDCOV project. 

In support of communities, civil society organisations, international and regional organisations and individuals living with and affected by HIV/AIDS globally, the European AIDS Treatment Group (EATG) and its members echo that the US administration should in all cases uphold the rights, dignity and freedom of vulnerable populations including migrants, transgender people, people living with HIV and those belonging to key populations.

We are excited to announce the return of the SCOPE project – Amplifying Community Voices for Prevention! This year, SCOPE continues to place a stronger emphasis on building meaningful partnerships with community-led groups and activists.

In the ‘HIV Voices for Transformation | HIV in prison’ webinar, we will discuss the experience of living with HIV in prison and how we can effect meaningful change in the lives of people living with HIV in closed settings.

On January 16 and 17, the Research in Europe and Diversity Inclusion (READI) consortium met at the Hospital Universitario La Paz, Madrid, Spain for the official launch of the project. As a consortium partner, the European AIDS Treatment Group (EATG) plays a pivotal role in the READI project by representing the community’s voice.    

READI project launches to enhance patient representativeness and inclusion in clinical research. EATG joins this project in collaboration with more than 70 partners across 18 countries, aiming to foster health equity and to improve the quality of clinical research across Europe. With a legacy of more than 30 years in patient advocacy, EATG represents the voice of the community in READI. EATG has been a steadfast ambassador for the inclusion of underserved and underrepresented groups of patients in clinical studies.    

The pioneering project READI —Research in Europe and Diversity Inclusion—a public-private partnership funded by the Horizon Europe Innovative Health Initiative (IHI) and driven by meaningful co-leadership with patients, officially launches today. With a legacy of more than 30 years in patient advocacy, the European AIDS Treatment Group (EATG) represents the voice of the community in READI. EATG has been a steadfast ambassador for the inclusion of underserved and underrepresented groups of patients in clinical studies.

The 10th STEPS HIV Cure community-led workshop took place on November 10, 2024,  ahead of HIV Glasgow 2024 conference. This is a summary report from the workshop.

On this year’s World AIDS Day, the European AIDS Treatment Group (EATG), Correlation – European Harm Reduction Network (C-EHRN) and Fundacja Edukacji Spolecznej (FES) are organising a face-to-face roundtable in Warsaw (Poland). The roundtable takes place in the frame of CORE – COmmunity REsponse to End Inequalities. We aim to bring together policymakers, healthcare professionals, community leaders, civil society organisations, and international partners to discuss gaps, barriers, and potential solutions to achieving the 95-95-95 targets set by the UNAIDS by 2025 in Poland and in the region. Leading up to the 1st of December, we blast community messages from across Europe, reflecting on how no one is left behind in the fight to end HIV/AIDS and inequalities.

The CSF organises this meeting to engage community organisations and representatives to review current issues concerning sexually transmitted infections (STIs), sexual health, well-being, and substance use.